Skip to content

Clinical trials

Completed Retinal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Status: Completed Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20031
20041
20052
20063
20076
20083
20091
20103
20114
20124
20132
20145
20153
20163
20173
20182
20198
20208
20213
20223
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)13
Optos, PLC4
Kodiak Sciences Inc3
Neurotech Pharmaceuticals3
Nidek Co. LTD.3
Unity Biotechnology, Inc.3
Adverum Biotechnologies, Inc.2
LKC Technologies, Inc.2
National Institute of Neurological Disorders and Stroke (NINDS)2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases82
Eye Diseases24
Macular Degeneration16
Diabetic Retinopathy14
Retinal Degeneration14
Macular Edema12
Diabetes Mellitus9
Glaucoma7
Vision Disorders7
Retinal Vein Occlusion5

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.